1224 related articles for article (PubMed ID: 19886317)
1. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
[TBL] [Abstract][Full Text] [Related]
2. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
[TBL] [Abstract][Full Text] [Related]
3. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
5. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
[TBL] [Abstract][Full Text] [Related]
6. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
Goldstein SL; Leung JC; Silverstein DM
Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 in chronic renal failure and dialysis patients.
Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
[TBL] [Abstract][Full Text] [Related]
8. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
[TBL] [Abstract][Full Text] [Related]
10. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
[TBL] [Abstract][Full Text] [Related]
12. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
15. Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
Sayarlioglu H; Topal C; Sayarlioglu M; Dulger H; Dogan E; Erkoc R
Mediators Inflamm; 2004 Apr; 13(2):119-21. PubMed ID: 15203553
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pretransplant serum cytokine levels in renal transplant recipients.
Berber I; Yiğit B; Işitmangil G; Tellioğlu G; Ozgezer T; Gülle S; Türkmen F; Titiz I
Transplant Proc; 2008; 40(1):92-3. PubMed ID: 18261555
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.
Siu YP; Leung KT; Tong MK; Kwan TH; Mok CC
Nephrol Dial Transplant; 2005 Dec; 20(12):2797-802. PubMed ID: 16204302
[TBL] [Abstract][Full Text] [Related]
20. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
